Amendment to Aligos Therapeutics, Inc. 2020 Incentive Award Plan

Contract Categories: Human Resources › Bonus & Incentive Agreements
Summary

This amendment, made by the Board of Directors of Aligos Therapeutics, Inc. and subject to stockholder approval, modifies the company's 2020 Incentive Award Plan. The main change is an increase in the number of shares available for issuance under the plan by 1,000,000 shares. All other terms of the plan remain unchanged. The amendment is effective upon approval by the company's stockholders.

Read More Arrow
EX-10.1 3 d98914dex101.htm EX-10.1 EX-10.1

Exhibit 10.1

AMENDMENT TO

ALIGOS THERAPEUTICS, INC.

2020 INCENTIVE AWARD PLAN

THIS AMENDMENT (this “Amendment”) to the Aligos Therapeutics, Inc. 2020 Incentive Award Plan, as amended (the “Plan”), is made and adopted by the Board of Directors (the “Board”) of Aligos Therapeutics, Inc., a Delaware corporation (the “Company”), subject to, and effective upon, the approval of the Company’s stockholders (the date of such approval, the “Effective Date”). All capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Plan.

RECITALS

WHEREAS, pursuant to Section 11.4 of the Plan, the Board has the authority to amend the Plan from time to time, including to increase the maximum aggregate number of Shares available for issuance thereunder, subject to approval of the Company’s stockholders; and

WHEREAS, the Board believes it is in the best interests of the Company and its stockholders to amend the Plan as set forth herein.

NOW, THEREFORE, BE IT RESOLVED, that the Plan is hereby amended as follows, subject to approval of the increase in reserved Shares provided by this Amendment by the Company’s stockholders:

AMENDMENT

 

  1.

The word “and” preceding subclause (iii) of Section 2.28 of the Plan is hereby deleted, and new subclause (iv) shall be added to Section 2.28 of the Plan to read as follows:

“; and (iv) 1,000,000 Shares.”

 

  2.

This Amendment shall be and is hereby incorporated into and forms a part of the Plan.

 

  3.

Except as expressly provided herein, all terms and conditions of the Plan shall remain in full force and effect.

(Signature Page Follows)

The undersigned, being the duly appointed and acting Assistant Secretary of Aligos Therapeutics, Inc., hereby certifies that the foregoing amendment was duly approved and adopted by the Board of Directors of the Company and stockholders of the Company effective as of the date first referenced above.

 

/s/ Lesley Ann Calhoun

Lesley Ann Calhoun
Assistant Secretary

[Signature Page to Amendment to the Aligos Therapeutics, Inc. 2020 Incentive Award Plan]